Abeona Therapeutics (ABEO) Revenue (2011 - 2026)

Abeona Therapeutics' Revenue history runs 13 years deep, the most recent figure standing at $8.7 million for Q1 2026.

• In Q1 2026, Revenue changed N/A year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $14.5 million (changed N/A YoY), while the FY2025 annual figure was $5.8 million, changed N/A from the prior year.
• Revenue for Q1 2026 stood at $8.7 million, up from $5.4 million in the prior quarter.
• The five-year high for Revenue was $8.7 million in Q1 2026, with the low at $68000.0 in Q4 2022.
• The 4-year median for Revenue is $1.0 million (2022), against an average of $2.8 million.
• Peak annual rise in Revenue reached 250.0% in 2023, while the deepest fall reached 250.0% in 2023.
• Abeona Therapeutics' Revenue stood at $68000.0 in 2022, then jumped by 5047.06% to $3.5 million in 2023, then jumped by 54.86% to $5.4 million in 2025, then jumped by 60.89% to $8.7 million in 2026.
• Business Quant data shows ABEO's Revenue at $8.7 million in Q1 2026, $5.4 million in Q4 2025, and $400000.0 in Q2 2025.